A CaCO3-crystal-growth inhibitor was isolated from human pancreatic stones by using EDTA demineralization, followed by DEAE-Trisacryl chromatography. The isolated inhibitor was found to be a phosphoglycoprotein with M, 14017 and having an unusual chemical composition. It is characterized by a high (42%) acidic amino acid content, but lacks methionine and y-carboxyglutamic acid. The protein contains 2.65 mol of P/mol of protein, as phosphoserine (2mol) and phosphothreonine (0.5 mol). Isoelectric focusing of the protein yields one major band corresponding to an isoelectric point of 4.2. Immunochemical quantification of the crystal-growth inhibitor in pure pancreatic juice reveals that it constitutes 14% of the normal exocrine secretion. Our findings demonstrate that this is a novel secretory protein, which has no enzymic activity and which maintains pancreatic juice in a supersaturated state with respect to CaCO3.
A CaCO3-crystal-growth inhibitor was isolated from human pancreatic stones by using EDTA demineralization, followed by DEAE-Trisacryl chromatography. The isolated inhibitor was found to be a phosphoglycoprotein with M, 14017 and having an unusual chemical composition. It is characterized by a high (42%) acidic amino acid content, but lacks methionine and y-carboxyglutamic acid. The protein contains 2.65 mol of P/mol of protein, as phosphoserine (2mol) and phosphothreonine (0.5 mol). Isoelectric focusing of the protein yields one major band corresponding to an isoelectric point of 4.2. Immunochemical quantification of the crystal-growth inhibitor in pure pancreatic juice reveals that it constitutes 14% of the normal exocrine secretion. Our findings demonstrate that this is a novel secretory protein, which has no enzymic activity and which maintains pancreatic juice in a supersaturated state with respect to CaCO3.
Human pancreatic lithiasis, also referred to as chronic calcifying pancreatitis, is characterized by the formation of intraductal stones (Sarles, 1974) . In contrast with other forms of human lithiasis, pancreatic stones contain a single type of crystalline component (up to 95% by weight), which has been identified as CaCO3, in the form of calcite (Mallet-Guy et al., 1969) .
Human pancreatic juice contains substantial HCO3-and Ca2+ concentrations. Since CaCO3 is very sparingly soluble (Ksp = 4.01 x 1O-9M2; Langmuir, 1968) , the juice is usually supersaturated (lithogenic) with respect to Ca2+ and carbonate. Hence, it would be expected that, under normal physiological conditions, CaCO3 would crystallize spontaneously. However, there is no indication that this occurs to any measurable extent.
The participation of specific macromolecules in maintaining a stable supersaturation state has been recognized in many body fluids (e.g. bile,
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t To whom correspondence and requests for reprints should be addressed. saliva, urine); however, little is known about the mechanisms operating in pancreatic juice.
It has been reported that one particular protein (M, 13 500) predominates in pancreatic stones (De Caro et al., 1979) . This protein was referred to as pancreatic-stone protein (PSP). It has also been found in the pancreatic juice of normal individuals.
Immunocytochemical localization of the PSP at the electron-microscopic level in pancreatic zymogen granules (Lechene de la Porte et al., 1981) suggests a similar secretory pathway to that described for digestive enzymes. In addition, it has been shown that PSP strongly inhibits precipitation in supersaturated CaCO3 solutions, a property that is not possessed by other pancreatic secretory proteins, glycosaminoglycans or Ca2+-chelators (Multigner et al., 1983a) . This suggests that PSP may be important in stabilizing pancreatic secretion. In view of this significant physiological role, further investigation was undertaken, and the present paper describes the purification and characterization of PSP in an attempt to clarify the inhibitory mechanism of CaCO3-crystal-growth the meeting of the American Gastroenterological Association, Washington, DC, May 1983.
Materials and methods

Materials
Human pancreatic stones were obtained at operation from 61 patients with chronic calcifying pancreatitis. Pure human pancreatic juice, devoid of free proteolytic activity, was obtained by endoscopic pancreatic cannulation as previously described (Sahel & Sarles, 1979) . Human pancreatic carboxylic ester hydrolase , lipase (De Caro et al., 1977) , pro-phospholipase A2 (Grataroli et al., 1981) , trypsinogens 1 and 2 , chymotrypsinogens A and B (De Caro et al., 1975) and amylase , were purified as described in the references cited. Bovine trypsin (once crystallized) was purchased from Worthington Biochemical Corp. Bovine prothrombin, phosvitin from egg vitellin, O-phosphoserine, O-phosphothreonine, DL-norleucine methyl ester and 1-(3-dimethylaminopropyl)-3-ethylcarbodi-imide chloride were purchased from Sigma Chemical Co. y-Carboxyglutamic acid was obtained from Bachem. Protein standards for calibration of polyacrylamide gels, Ampholines and agarose A were from Pharmacia, and reagents for polyacrylamide-gel preparation were supplied by Bio-Rad Laboratories. Water used in all solutions was double-distilled, and all other chemicals were of the highest available grade.
Enzyme assays
When the chromatography was performed in the presence of benzamidine, fractions containing chymotrypsinogen and pro-phospholipase A2 were activated with bovine trypsin (50% by wt.) before assay. Chymotrypsin and phospholipase activities were measured with lOmM-Ac-Tyr-OEt solution and egg-yolk emulsion as substrates respectively (Figarella, 1966; Grataroli et al., 1981) . Carboxylic ester hydrolase activity was determined spectrophotometrically at 400nm with p-nitrophenyl acetate as substrate . Lipase activity was assayed with tributyrylglycerol emulsion (Lombardo et al., 1980) , and lysozyme activity was determined with suspensions of Micrococcus lysodeikticus (Shugar, 1952) . Effects of co-lipase and phospholipase A2 activity on monomolecular films were measured in a special zeroorder trough as described by Verger & De Haas (1973) , with the use of the barostat method. 1,3-Dihexanoylglycerol was used as the substrate for lipase, and phosphatidylcholine for phospholipase (Rietsch et al., 1977 Laemmli (1970) technique. Cylindrical gels (0.5 cm internal diam. x 12cm) were used that contained 15% acrylamide and 0.4% NN'-methylenebisacrylamide. After electrophoresis, protein bands containing PSP were rapidly cut out from the gels after careful alignment with a stained gel by using the method of Chrambach et al. (1967) . The bands of PSP were placed in a 5 ml tissue-homogenization tube containing 2ml of 0.15M-NaCl and were homogenized with a motor-driven Teflon pestle. The gel particles, containing about 0.9mg of antigen, were then emulsified with 2 ml of Freund's complete adjuvant and administered by multiple subcutaneous injections. Three booster doses were given at weekly intervals. After a month's interval, two successive boosters were administered at 1-month intervals. Blood was collected 1 week after the fourth and the sixth immunizations, and the serum was stored at -30°C. Antisera to normal unactivated or activated human pancreatic juice were prepared by immunization of rabbits as described previously (Clemente et al., 1971 ). Immunological techniques Double-immunodiffusion analysis was carried out either by following the Ouchterlony (1949) method or by immunoelectrophoresis as described by Osserman (1960) . The plates contained 1.5% agarose A in 25 mM-Veronal/acetate buffer, pH 8.6, containing 5 mM-benzamidine. Quantitative measurements of PSP were performed by radial immunodiffusion. Plastic plates (85mm x 95mm) were overlaid with 1.5% agarose A in Veronal/acetate buffer containing 5 mM-benzamidine mixed with 1.5ml of anti-PSP serum at 56°C. Linear standard curves were obtained, by plotting the squared diameters of the rings as a function of the PSP concentration, the latter varying between 2 and 30pg/ml for the standards. Samples of higher PSP concentrations were diluted within this range. The lower detection limit of this technique was approx. 0.5ig/ml. The concentration of PSP used for the standards was determined by amino acid analysis.
PSP assays
Chromatographic elution patterns of PSP were obtained by immunochemical measurements as described above and also by testing samples of column fractions for their ability to inhibit spontaneous CaCO3 precipitation from supersaturated solutions by using the procedure outlined by Multigner et al. (1983a) . SDS/polyacrylamide-gel electrophoresis Polyacrylamide-slab-gel electrophoresis in the presence of SDS was carried out in 15% gel (Laemmli, 1970) with an LKB 2001 apparatus. Mr measurements were made on proteins that had been reduced with dithiothreitol (200mM) and alkylated with iodoacetamide (100mM) for 15min in darkness. Protein bands were rendered visible by staining with Coomassie Blue R250 followed by destaining in acetic acid/methanol/water (1:3:6, by vol.).
For an initial survey of carbohydrate content, a gel electrophoretogram of pure PSP was stained by the periodic acid/Schiff procedure as described by Glossmann & Neville (1971) . As controls bovine trypsinogen and human pancreatic lipase were used.
Isoelectric focusing
Isoelectric focusing in polyacrylamide slab gel was performed with a Pharmacia FBE 3000 flatbed apparatus. The gels contained 4.85% acrylamide, 0.13% NN'-methylenebisacrylamide, 8M-urea or 0.30M-sucrose and 2.5% Ampholine pH 3-10.
Focusing was performed at constant power for 2h. For pI determinations, focusing strips were sliced and the profile of the pH gradient was established by measuring the pH of each slice. Protein bands were rendered visible by the silver technique of Merril et al. (1981) .
Amino acid analysis
Amino acid analyses were performed in duplicate in a Beckman automatic analyser (model 119 CL) after 24h, 48 h and 72h of hydrolysis at 108°C (6nmol of protein was added to an internal standard of 0.1umol of norleucine in 0.25ml of 5.6M-HCI in vacuum-sealed tubes). The individual values obtained for each residue were averaged, except in the cases of serine and threonine, for which linear extrapolations to zero time were made. Half-cystine and methionine were determined as cysteic acid and methionine sulphone after performic acid oxidation (Moore, 1963) . Tryptophan was determined after NaOH hydrolysis by using the method of Wilkinson et al. (1976) .
O-Phosphoserine and O-phosphothreonine were determined chromatographically on the Beckman analyser by using the Cohen-Solal et al. (1978) procedure after partial acid hydrolysis in 4M-HCI for periods of 4h, 6h and 8 h. For the separation of O-phosphoserine from O-phosphothreonine a fresh solution of 0.2M-sodium citrate at pH 1.5 was employed. Calculated values were extrapolated to zero time. y-Carboxyglutamic acid was determined after alkaline hydrolysis under N2 as described by Hauschka (1977) . The method of Delaage (1968) is used to determine the Mr of PSP from the amino acid analysis.
The glutamic acid and aspartic acid contents were determined after chemical modification with 1-(3-dimethylaminopropyl)-3-ethyl carbodi-imide and norleucine methyl ester of denatured PSP as described by Lombardo (1982) . In order to calculate the total number of norleucine residues released, stable amino acids were used. Calculations were then based on the known number of each residue present per molecule of PSP.
N-Terminal residue
The N-terminal residue was determined by dansylation as described by Gray (1972) . The resulting dansyl-amino acid was identified by polyamide t.l.c. (Woods & Wang, 1967 As noted above, the SDS/polyacrylamide-gel electrophoretograms of most of the extracts revealed the presence of at least three proteins. So, crude PSP was further purified by DEAE-Trisacryl M chromatography. As shown in Fig. 1 residues for 5.5% of all amino acids. No methionine and only 1 mol of tryptophan/mol were detected. To determine the presence of unusual amino acids, such as y-carboxyglutamic acid and phosphorylated residues, the protein was subjected to hydrolysis as indicated in the Materials and methods section. Synthetic y-carboxyglutamic acid and y-carboxyglutamic acid present in the hydrolysate of bovine prothrombin were used as references. No y-carboxyglutamic acid was, however, found in the hydrolysate. Of particular interest is the finding of phosphorylated amino acids in the protein. Two 
Isoelectric focusing
Isoelectric focusing of the protein carried out in the presence of sucrose showed an acidic set of bands. We observed a main band with pI4.2 and two minor bands with pI4.5 and 4.7. In the presence of 8 M-urea the same pattern was observed, but the higher pI values 5.1, 5.5 and 5.8 respectively were observed. However, after a correction was made for the effect of urea on the pH of aqueous solutions, as described by Ui (1971) , the difference in isoelectric points in the presence and in the absence of urea was minimal. Fig. 3 . Double-immunodiffusion test of trypsin I (1) and PSP (2) against an antiserum to human pancreaticjuice (S) + s were tested either by double diffusion or by immunoelectrophoresis against purified PSP and non-activated human pancreatic juice. These precipitation lines showed complete fusion, as expected, indicating immunological identity. Identical results were obtained after substitution of anti-PSP serum for antiserum to human pancreatic juice. It may be noted that the immunoreactive form of stone protein in pancreatic juice and that isolated from pancreatic stones have a similar electrophoretic mobility (Fig. 4) . Anti-PSP serum was used for the quantitative determination of PSP by radial immunodiffusion in pure pancreatic juice of five patients who possessed normal pancreatic function. The results showed that this protein is a constant and a significant constituent of pancreatic juice (about 14% of total proteins).
Chromatographic behaviour of immunoreactive PSP by gel filtration on Sephadex G-100
Results from gel filtration of human pancreatic juice on Sephadex G-100 revealed an elution diagram with four peaks of protein (Fig. 5) . Peak I contained the high-M, proteins (Mr > 100000), whereas the average M, value of peak II did not exceed 50000, since lipase activity was detected in this fraction. Proteins eluted under peak III possessed chymotryptic and phospholipase A2 activities, thus corresponding to proteins with Mr 15000-25000. The elution profile of PSP was checked by quantitative radial-immunodiffusion assays of the column fractions. One peak of immunoreactive material was present that contained 85% of the total immunoreactive PSP. This peak was located in a position consistent with an apparent Mr of approx. 25000. Moreover, only the fractions corresponding to the peak of immunoreactive PSP inhibited spontaneous CaCO3 precipitation. The column (2cm x 170cm) was equilibrated and developed with l0mM-Tris/HCl buffer, pH8.0, containing 500mM-NaCl and mM-benzamidine at 40C. The sample contained 297mg of protein; the fraction volume was 3.1 ml and the void volume was 165 ml. (a) shows A280 (------) and the elution profiles for carboxylic ester hydrolase (A), lipase (El), chymotrypsinogen (a) and pro-phospholipase A2 (A). (b) shows the concentration of PSP (0) measured by radial immunodiffusion, the hatched area indicating eluted fractions containing an inhibitory activity towards spontaneous CaCO3 precipitation.
Discussion
We have described the isolation and characterization of a CaCO3-crystal-growth inhibitor from human pancreatic stones. The purification procedure included two steps: EDTA demineralization and chromatography on DEAETrisacryl at pH 8.0. The purified inhibitor was found to be a phosphoglycoprotein and comprised approx. 0. 15% (by wt.) of the dried calculi. Its Mr, determined by SDS/polyacrylamide-gel electrophoresis, was found to be 13 500, agreeing well with the value of 14017 calculated from the amino acid composition. In gel filtration on a Sephadex G-100 column its elution position indicated that the apparent M, is approx. 25000. This value is greater than that expected from analysis of the amino acid composition and electrophoresis. Such elution behaviour could be explained by an unusual protein conformation. The inhibitor contained an unusually large percentage of acidic amino acids (42%) and smaller percentages of aliphatic amino acids (22%). In contrast, the proportions of basic (4.7%) and aromatic amino acids (5.5%) were rather low. The fact that the inhibitor contained few aromatic amino acid residues explains its atypical u.v.-absorption spectrum, with an absorption maximum at 272 instead of 280 nm, and also explains the weak staining with Coomassie Blue after polyacrylamide-gel electrophoresis. The analysis for y-carboxyglutamic acid was undertaken because of the importance of this . (Nelsestuen & Suttie, 1973; Stenflo et al., 1974) and the fact that PSP is a Ca2+-binding protein (Lohse et al., 1982) . In addition, the presence of a y-carboxyglutamic acid-containing protein (M, 17000) has also been reported in renal stones (Lian et al., 1977 (Multigner et al., 1983a) . (e) When non-activated pancreatic juice proteins were subjected to gel filtration on Sephadex G-100, the fractions containing immunoreactive PSP (detected by radial immunodiffusion) also inhibited CaCO3 precipitation. These fractions, which contained the inhibitory activity, were then applied to a DEAE-Trisacryl column, developed with a linear gradient of NaCl. In the resultant chromatographic elution profile one peak was detected which possessed no enzymic activity and contained a protein that was virtually pure. This latter exhibited an inhibitory activity towards supersaturated CaCO3 solutions and possessed complete immunological identity with PSP when tested against an anti-PSP serum by the Ouchterlony method. Moreover, its Mr, estimated by SDS/polyacrylamide-gel electrophoresis, was found to be 13500.
Thus the elution profile of the inhibitor on DEAE-Trisacryl corresponds to an unknown protein peak previously described by our laboratory (Figarella et al., 1969 (Wheeler et al., 1981) , an acid polysaccharide associated with the coccoliths of Emiliania huxleyi (Borman et al., 1982) and human PSP.
A scheme implicating a crucial role for inhibitors of pancreatic stone formation assumes that the inhibitors are deficient in the pancreatic juice of patients presenting with such calculi. Our observation that the secretion of PSP is decreased in chronic calcifying pancreatitis (Multigner et al., 1983b) supports this. We believe that the presence of this phosphoprotein in calculi is significant and that it plays an important role in the prevention of pancreatic stone formation. When the PSP con-centration is insufficient to block all active sites, crystal growth, although decreased, is not suppressed. Continued growth incorporates PSP that is already fixed on to the growth sites into the crystal lattice, thus explaining why PSP is found in pancreatic calculi.
We consider the molecular properties of PSP to be proof of the existence of a previously unrecognized secretory protein. It seems likely that a similar inhibitor exists in other mammalian pancreatic secretions to prevent injurious precipitation in the supersaturated pancreatic juice. Experiments are now required to test this possibility.
